Literature DB >> 2180562

Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability.

J M Mullin1, K V Snock.   

Abstract

The serum factor inducing hemorrhagic necrosis of transplantable tumors [tumor necrosis factor (TNF)], and the macrophage hormone associated with cachexia in cancer and certain infectious diseases [cachectin] are known to be the same protein. Because an association may exist between TNF and the cachectic state, we wished to examine the effect of TNF on the permeability of epithelial barriers. We present data showing that TNF affects the tight junctional region between epithelial cells, lowering the transepithelial resistance and potential difference, and increasing the flow of solute between cells and across the epithelium. These effects are dose dependent, rapidly reversible, and inhibited by a monoclonal antibody to TNF-alpha. We suggest that the release of TNF at various sites throughout the body will cause a general breakdown in the barrier function of an epithelial cell sheet. This may relate to the cachexia observed in certain disease states. These findings are similar to our earlier published effects of phorbol esters and diacylglycerols on tight junctions, suggesting that protein kinase C activation may be involved.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180562

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.

Authors:  J Bauditz; S Wedel; H Lochs
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

2.  Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration.

Authors:  N Hida; T Shimoyama; P Neville; M F Dixon; A T Axon; T Shimoyama; J E Crabtree
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

3.  Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.

Authors:  V Lorenzo-Zúñiga; C M Rodríguez-Ortigosa; R Bartolí; M-L Martínez-Chantar; L Martínez-Peralta; A Pardo; I Ojanguren; J Quiroga; R Planas; J Prieto
Journal:  Gut       Date:  2006-01-24       Impact factor: 23.059

Review 4.  Stimulus-induced reorganization of tight junction structure: the role of membrane traffic.

Authors:  Dan Yu; Jerrold R Turner
Journal:  Biochim Biophys Acta       Date:  2007-08-24

5.  Inflammatory mediators increase surface expression of integrin ligands, adhesion to lymphocytes, and secretion of interleukin 6 in mouse Sertoli cells.

Authors:  A Riccioli; A Filippini; P De Cesaris; E Barbacci; M Stefanini; G Starace; E Ziparo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 6.  Cytokine regulation of epithelial permeability and ion transport.

Authors:  D M McKay; A W Baird
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

7.  LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.

Authors:  Brad T Schwarz; Fengjun Wang; Le Shen; Daniel R Clayburgh; Liping Su; Yingmin Wang; Yang-Xin Fu; Jerrold R Turner
Journal:  Gastroenterology       Date:  2007-02-27       Impact factor: 22.682

8.  Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat.

Authors:  J L Wright; R E Merchant
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 9.  Cytokine regulation of tight junctions.

Authors:  Christopher T Capaldo; Asma Nusrat
Journal:  Biochim Biophys Acta       Date:  2008-10-08

10.  Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer.

Authors:  E C De Boer; W H De Jong; P A Steerenberg; L A Aarden; E Tetteroo; E R De Groot; A P Van der Meijden; P D Vegt; F M Debruyne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.